x

Search for an orphan drug

* (*) mandatory field

Other search option(s)

Marketing authorization without orphan designation - Europe

Therapeutic indication

In combination with cisplatin and 5-fluorouracil is indicated for the induction treatment of patients with locally advanced squamous cell carcinoma of the head and neck.

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.